Stones by zodiac signs

How many days can you take bismuth?

1 tablet contains the active substance: bismuth tripotassium dicitrate – 304,6 mg, in terms of bismuth oxide – 120,0 mg.

Pharmacotherapeutic group

Antiulcer, antiseptic, intestinal and astringent

ATX code

pharmachologic effect

Gastroprotective and antiulcer agent with bactericidal activity against Helicobacter pylori. It also has anti-inflammatory and astringent effects. In the acidic environment of the stomach, insoluble bismuth oxychloride and citrate are precipitated, and chelate compounds are formed with the protein substrate in the form of a protective film on the surface of ulcers and erosions. Thus, the drug forms a protective layer, which for a long period of time protects the affected areas of the mucous membrane from the influence of aggressive factors. By increasing the synthesis of prostaglandin E, mucus formation and bicarbonate secretion, it stimulates the activity of cytoprotective mechanisms, increases the resistance of the gastrointestinal mucosa to the effects of pepsin, hydrochloric acid, enzymes and bile salts. Leads to the accumulation of epidermal growth factor in the defect area. Reduces the activity of pepsin and pepsipogen.

Indications for use

• functional dyspepsia not associated with organic diseases of the gastrointestinal tract; • chronic gastritis and gastroduodenitis in the acute phase, including those associated with Helicobacter pylori; • peptic ulcer of the stomach and duodenum in the acute phase, including those associated with Helicobacter pylori; • irritable bowel syndrome, which occurs predominantly with symptoms of diarrhea.

Противопоказания

• increased individual sensitivity to the components of the drug; • pregnancy; • breastfeeding period; • taking medications containing bismuth; • chronic renal failure; • children under 4 years of age.

Dosing and Administration

Inside. The duration of the course of treatment and the dose of the drug are determined by the attending physician individually for each patient, depending on the nature of the disease. For adults and children over 12 years of age, the drug is prescribed 1 tablet 4 times a day, 30 minutes before meals (breakfast, lunch, dinner) and at night, or 2 tablets 2 times a day 30 minutes before meals (breakfast, dinner). Children aged 8 to 12 years are prescribed 1 tablet 2 times a day, 30 minutes before meals (breakfast, dinner). Children aged 4 to 8 years are prescribed a dose of 8 mg/kg/day; Depending on the child’s body weight, 1-2 tablets are prescribed per day (respectively, in 1-2 doses per day). In this case, the daily dose should be as close as possible to the calculated dose (8 mg/kg/day). The tablets are taken 30 minutes before meals with a small amount of water. It is recommended to swallow the tablet whole, without chewing or crushing, with a sufficient amount of water. It is not recommended to take the tablets with milk. The duration of treatment is usually from 4 to 8 weeks. After finishing taking the drug, it is not recommended to take medications containing bismuth (for example, Vikalin, Vikair) for 2 months. To eradicate Helicobacter pylori, it is advisable to use bismuth tripotassium dicitrate in combination with antibacterial drugs that have anti-Helicobacter activity.

Form of issue

Film-coated tablets 120 mg. 7, 10, 14, 28, 30 tablets in blister packs made of polyvinyl chloride film and printed varnished aluminum foil. 7, 10, 14, 20, 28, 30, 50, 56, 60, 100, 112, 160 or 240 tablets in polyethylene terephthalate for medicines or polypropylene for medicines, sealed with high-density polyethylene lids with first opening control or polypropylene lids with a “push-turn” system or low-density polyethylene lids with first-opening control.

Availability of Bismuth tripotassium dicitrate, film-coated tablets 120 mg, 56 pcs in Kovrov pharmacies

All pharmacies
Product in stock
List Map
Pharmacy
Hours of operation
In stock
Not available
‘ title=’Your favorite pharmacy will be the first in the list of pharmacies in product cards and when placing an order.’>
‘ title=’Your favorite pharmacy will be the first in the list of pharmacies in product cards and when placing an order.’>
Not available
Show 10 more No pharmacies found, please try other search terms.

Analogues of the active substance Bismuth tripotassium dicitrate

Analogs of Bismuth tripotassium dicitrate, film-coated tablets 120 mg, 56 pcs.

Description

Active substance:
Bismuth tripotassium dicitrate Dosage form:
film-coated tablets
Composition:
Composition per tablet: Active ingredient: bismuth tripotassium dicitrate – 304,6 mg, in terms of bismuth oxide – 120,0 mg. Excipients: corn starch 71,1 mg; potassium polyacrylate – 23,6 mg; povidone-K25 – 17,7 mg: macrogol-6000 – 6,0 mg; magnesium stearate – 2,0 mg. Shell composition: hypromellose – 5,5 mg; titanium dioxide – 3.0 mg; macrogol-4000 – 1,5 mg. Description:
Round, biconvex, film-coated tablets, white or almost white, odorless or with a slight characteristic odor. On a cross section, two layers are visible: the core is white or white with a yellowish tint and the film shell.
Pharmacotherapeutic group:
Antiulcer, antiseptic, intestinal and astringent
ATX:
A.02.BX05 Bismuth tripotassium dicitrate Pharmacodynamics:
Gastroprotective and antiulcer agent with bactericidal activity against Helicobacter pylori. It also has anti-inflammatory and astringent effects. In the acidic environment of the stomach, insoluble bismuth oxychloride and citrate are precipitated, and chelate compounds are formed with the protein substrate in the form of a protective film on the surface of ulcers and erosions. Thus, the drug forms a protective layer, which for a long period of time protects the affected areas of the mucous membrane from the influence of aggressive factors. By increasing the synthesis of prostaglandin E, mucus formation and bicarbonate secretion, it stimulates the activity of cytoprotective mechanisms, increases the resistance of the gastrointestinal mucosa to the effects of pepsin, hydrochloric acid, enzymes and bile salts. Leads to the accumulation of epidermal growth factor in the defect area. Reduces the activity of pepsin and pepsinogen. Pharmacokinetics:
Practically not absorbed from the gastrointestinal tract. It is excreted mainly in feces. A small amount of bismuth entering the plasma is excreted from the body by the kidneys. Indications:
– Functional dyspepsia not associated with organic diseases of the gastrointestinal tract; – chronic gastritis and gastroduodenitis in the acute phase, including those associated with Helicobacter pylori; – peptic ulcer of the stomach and duodenum in the acute phase, including that associated with Helicobacter pylori; – irritable bowel syndrome, which occurs predominantly with symptoms of diarrhea. Contraindications:
– Increased individual sensitivity – period of breastfeeding; – taking medications containing bismuth; – chronic renal failure; – children under 4 years of age. Pregnancy and lactation:
Bismuth tripotassium dicitrate is contraindicated for use in pregnant women. If it is necessary to use the drug during lactation, breastfeeding should be stopped. Dosing and Administration:
Inside. The duration of the course of treatment and the dose of the drug are determined by the attending physician individually for each patient, depending on the nature of the disease. For adults and children over 12 years of age, the drug is prescribed 1 tablet 4 times a day, 30 minutes before meals (breakfast, lunch, dinner) and at night, or 2 tablets 2 times a day 30 minutes before meals (breakfast, dinner). Children aged 8 to 12 years are prescribed 1 tablet 2 times a day, 30 minutes before meals (breakfast, dinner). Children aged 4 to 8 years are prescribed at a dose of 8 mg/kg/day: depending on the child’s body weight, 1-2 tablets per day are prescribed (respectively, in 1-2 doses per day). In this case, the daily dose should be as close as possible to the calculated dose (8 mg/kg/day). The tablets are taken 30 minutes before meals. with a small amount of water. It is recommended to swallow the tablet whole, without chewing or crushing, with a sufficient amount of water. It is not recommended to take the tablets with milk. The duration of treatment is usually from 4 to 8 weeks. 11After finishing taking the drug, it is not recommended to take medications containing bismuth (for example, Vikalin, Vikair) for 2 months. To eradicate Helicobacter pylori, it is advisable to use bismuth tripotassium dicitrate in combination with antibacterial drugs that have anti-Helicobacter activity. If there is no improvement during treatment, you should consult a doctor. Use the drug only according to the method of use and in the doses indicated in the instructions. If necessary, please consult your doctor before using the medicine. Side effects:
The following adverse events noted with the use of bismuth tripotassium dicitrate are distributed according to the frequency of occurrence in accordance with the following gradation: very often (≥ 1/10); often (≥ 1/100, < 1/10); uncommon (≥ 1/1, < 000/1); rare (≥ 100/1, From the gastrointestinal tract: very often - black stool; uncommon – nausea, vomiting, diarrhea or constipation. Allergic reactions: infrequently - skin rash, itching; very rarely - anaphylactic reactions. From the nervous system: very rarely - with long-term use in high doses - encephalopathy associated with the accumulation of bismuth in the central nervous system. Side effects are reversible and disappear quickly after discontinuation of the drug. If any of the side effects indicated in the instructions get worse, or you notice any other side effects not listed in the instructions, tell your doctor. Overdose:
When using the drug in doses tens of times higher than recommended, or with prolonged use of excessive doses of the drug, bismuth poisoning may develop. Symptoms: dyspepsia, rash, inflammation of the oral mucosa, characteristic darkening in the form of blue lines on the gums; with long-term use in doses exceeding the recommended ones, renal function may be impaired. These symptoms are completely reversible when the drug is discontinued. Treatment: there is no specific antidote. In case of an overdose of the drug, gastric lavage, intake of enterosorbents and symptomatic therapy aimed at maintaining kidney function are indicated. In case of overdose, the administration of saline laxatives is also indicated. Further treatment should be symptomatic. In case of impaired renal function, accompanied by a high level of bismuth in the blood plasma, complexing agents – dimercaptosuccinic and dimercaptopropanesulfonic acids – can be administered. With the development of severe renal dysfunction, hemodialysis is indicated. Interaction:
For half an hour before and half an hour after taking the drug, it is not recommended to take other medications internally, as well as take food and liquids, in particular antacids, milk, fruits and fruit juices. This is due to the fact that when taken orally simultaneously, they can affect the effectiveness of bismuth tripotassium dicitrate. The drug reduces the absorption of tetracyclines. The drug is not used simultaneously with other drugs containing bismuth, since the simultaneous use of several bismuth drugs increases the risk of side effects, including the risk of encephalopathy. Special instructions:
The drug should not be used for more than 8 weeks. It is not recommended to exceed the established daily doses for adults and children during treatment. During treatment with the drug, you should not use other drugs containing bismuth (see section “Interaction with other drugs”). At the end of a course of treatment with the drug in recommended doses, the concentration of the active substance in the blood plasma does not exceed 3-58 mcg/l, and intoxication is observed only at concentrations above 100 mcg/l. When using bismuth tripotassium dicitrate, stool may turn dark due to the formation of bismuth sulfide. Sometimes there is a slight darkening of the tongue. Alcohol consumption is not recommended during therapy. Impact on the ability to drive vehicles. Wed and fur.:
There are no data on the effect of the drug Bismuth tripotassium dicitrate on the ability to drive vehicles and operate machinery. Release form/dosage:
Film-coated tablets 120 mg. Packaging:
7, 10, 14, 28, 30 tablets in blister packs made of polyvinyl chloride film and printed varnished aluminum foil. 7, 10, 14, 20, 28, 30, 50, 56, 60, 100, 112, 160 or 240 tablets in polyethylene terephthalate for medicines or polypropylene for medicines, sealed with high-density polyethylene lids with first opening control or polypropylene lids with a “push-turn” system or low-density polyethylene lids with first-opening control. One can or 1, 2, 3, 4, 5, 6, 7, 8, 10 or 16 blister packs along with instructions for use are placed in a cardboard package (pack). It is allowed to complete 2 or 3 cardboard packages (packs) in a group package (transport container) made of cardboard for consumer packaging or imported. Storage conditions:
At a temperature not higher than 25 °C. Keep out of the reach of children. Shelf life:
3 years. Do not use after expiration date. Conditions for dispensing from pharmacies:
Without recipe

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button